“Malignant Gliomas:  Where have we been and where are we going?”

Friday, October 27, 2017

Walker Auditorium

12:30 p.m. – 1:30 p.m.

Lunch available on a first come, first served basis

Presented by:

Steven S. Rosenfeld, M.D., Ph.D.

Professor of Neurology

Hematology/Oncology

Mayo Clinic Florida

Learning Objectives:

Upon conclusion of this program, participants should be able to:

• Describe history of therapies for glioma
• Describe limitations of current glioma therapies
• Identify potential glioblastoma vulnerabilities.

  “Speaker, Doctor Steven Rosenfeld, has no financial relationships to disclose or intentions to discuss off-label/ investigational use of a commercial product device.”

  The Planning Committee members: Dr. James Foran, Jennifer Gatchell, Valerie Fernandez, and Linda Gibson have no relevant financial relationships to disclose.

  Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

  Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Please direct all inquiries for non-physician CEU’s to Clinical Education at (3-0326)

  For further information, contact  Jen Gatchell 3-2795